HighCape Partners

2013

Founded

12

Investments

United States

Offices

Venture Fund

Investor Type

About

HighCape Partners is a venture capital firm specializing in investments within the life sciences sector, focusing on companies that are developing innovative therapeutics, diagnostics, and medical devices. Established in 2013, the firm leverages its deep industry expertise and extensive network to identify and support high-potential companies at various stages of development. HighCape Partners is committed to advancing healthcare by partnering with visionary entrepreneurs to bring transformative solutions to market.

The firm's investment philosophy centers on providing strategic guidance, operational support, and access to a broad network of industry contacts to help portfolio companies achieve their objectives. Notable achievements include successful exits through acquisitions and public offerings, demonstrating the firm's ability to identify and nurture high-impact companies. HighCape Partners differentiates itself through its specialized focus on life sciences, its hands-on approach to portfolio management, and its commitment to fostering long-term partnerships with entrepreneurs.

Investment Focus

Investment Stage

HQ Locations

Portfolio Companies

TheraBiologics, MedTech Innovations, BioDiagnostics, GeneThera, CardioTech, NeuroPharm, OncoMed, VivaHealth, ImmunoTech, BioMedica

Gepgraphic Focus

United States, Europe

Key Differentiators

Specialized focus on life sciences, Hands-on approach to portfolio management, Commitment to long-term partnerships with entrepreneurs

Thypical Investment Size

$10 million to $50 million

Total Funds Raised

$500 million

Visit Website

BioTech

Series C

Series D

United States